[
  {
    "ts": "2025-11-11T00:00:00+00:00",
    "headline": "Eli Lilly cuts surprising deals with upstart biotech players",
    "summary": "Eli Lilly stock reached a new 52-week high on Nov. 10, up 4.7% and extending a month-long rally of 16%, after the pharmaceutical giant announced two strategic deals, following the highly anticipated deal with the White House. The move underlines Eli Lilly’s ambition to expand beyond its dominant ...",
    "url": "https://www.thestreet.com/investing/stocks/eli-lilly-cuts-surprising-deals-with-upstart-biotech-players",
    "source": "TheStreet",
    "provider": "yfinance",
    "raw": {
      "id": "3af520e7-cb4a-3151-a9fd-c264d4c52b6f",
      "content": {
        "id": "3af520e7-cb4a-3151-a9fd-c264d4c52b6f",
        "contentType": "STORY",
        "title": "Eli Lilly cuts surprising deals with upstart biotech players",
        "description": "",
        "summary": "Eli Lilly stock reached a new 52-week high on Nov. 10, up 4.7% and extending a month-long rally of 16%, after the pharmaceutical giant announced two strategic deals, following the highly anticipated deal with the White House. The move underlines Eli Lilly’s ambition to expand beyond its dominant ...",
        "pubDate": "2025-11-11T00:00:00Z",
        "displayTime": "2025-11-11T00:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/thestreet_881/57caa2ddd6451258ff2dbf63f7196090",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Z0L6ukO6JGXpAK26OgNTjA--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/thestreet_881/57caa2ddd6451258ff2dbf63f7196090.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/d3v49gU8yXup7hM9Rr7aaQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/thestreet_881/57caa2ddd6451258ff2dbf63f7196090.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "TheStreet",
          "url": "https://www.thestreet.com/"
        },
        "canonicalUrl": {
          "url": "https://www.thestreet.com/investing/stocks/eli-lilly-cuts-surprising-deals-with-upstart-biotech-players",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-cuts-surprising-deals-000000281.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T09:25:00+00:00",
    "headline": "Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?",
    "summary": "Three large pharmaceutical makers are jockeying for position in the rapidly expanding market for GLP-1 drugs.",
    "url": "https://www.fool.com/investing/2025/11/11/win-intense-battle-rule-glp-1-drug-lly-nvo-pfe/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "7600dc29-a7f0-397a-8c3c-7b2508f19c52",
      "content": {
        "id": "7600dc29-a7f0-397a-8c3c-7b2508f19c52",
        "contentType": "STORY",
        "title": "Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?",
        "description": "",
        "summary": "Three large pharmaceutical makers are jockeying for position in the rapidly expanding market for GLP-1 drugs.",
        "pubDate": "2025-11-11T09:25:00Z",
        "displayTime": "2025-11-11T09:25:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/0f189b86e73e67f4cf765d58dbf57476",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "A package of a weight-loss drug next to a barbell.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uy.JmKH8mGx7AIwWfdl7XA--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/0f189b86e73e67f4cf765d58dbf57476.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/A1zrw5Cb3qAMPzn97Rm55w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/0f189b86e73e67f4cf765d58dbf57476.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/11/win-intense-battle-rule-glp-1-drug-lly-nvo-pfe/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/whos-winning-intense-battle-rule-092500402.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]